Henry Schein Inc banner

Henry Schein Inc
XMUN:HS2

Watchlist Manager
Henry Schein Inc Logo
Henry Schein Inc
XMUN:HS2
Watchlist
Price: 66.25 EUR -1.49%
Market Cap: €8.6B

EV/GP

2.9
Current
2%
More Expensive
vs 3-y average of 2.8

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
2.9
=
Enterprise Value
€11.6B
/
Gross Profit
$4.1B

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
2.9
=
Enterprise Value
€11.6B
/
Gross Profit
$4.1B

Valuation Scenarios

Henry Schein Inc is trading above its 3-year average

If EV/GP returns to its 3-Year Average (2.8), the stock would be worth €65.21 (2% downside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-2%
Maximum Upside
+125%
Average Upside
51%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 2.9 €66.25
0%
3-Year Average 2.8 €65.21
-2%
5-Year Average 3 €67.83
+2%
Industry Average 5.2 €118.14
+78%
Country Average 6.5 €149.37
+125%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close

Market Distribution

Lower than 83% of companies in the United States of America
Percentile
17th
Based on 9 428 companies
17th percentile
2.7
Low
0 — 4.2
Typical Range
4.2 — 10.6
High
10.6 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 4.2
Median 6.5
70th Percentile 10.6
Max 1 764 211.7

Henry Schein Inc
Glance View

In the evolving landscape of healthcare distribution, Henry Schein Inc. has carved out a robust niche, establishing itself as a pivotal player in delivering essential products and services. Founded in 1932, the company initially responded to the growing need for medical supplies with a simple commitment to customer service and innovation. Today, the company profiles as the world’s largest provider of healthcare products and services to office-based dental and medical practitioners, alongside its veterinary arm. It services a global footprint, channeling its efforts into dental, medical, and animal health sectors. The company's sprawling network deploys a vast array of products—from consumables to equipment—to a multitude of healthcare professionals, accentuating its integral role in the clinical toolkit. Henry Schein's revenue engine thrives on a meticulously crafted business model that combines the breadth of a comprehensive catalog with targeted value-added services. Its diverse product offerings span dental implants, vaccines, pharmaceuticals, and surgical supplies, delivered through direct sales and sophisticated logistical frameworks. Moreover, Henry Schein supplements its product lines with a suite of services, including practice management solutions and e-commerce platforms, that streamline operations for practitioners and enhance client loyalty. Strategic partnerships and acquisitions show the company's commitment to innovation, driving efficiencies and expanding its reach. This continuous adaptation keeps Henry Schein at the forefront of healthcare trends, ensuring steady streams of income flowing from both longstanding relationships and new market opportunities.

HS2 Intrinsic Value
90.91 EUR
Undervaluation 27%
Intrinsic Value
Price €66.25
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett